The groundbreaking therapy of this peptide represents a significant advance in the management of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide693431.estate-blog.com/40862829/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment